Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

J. Schetelig, H. Baldauf, L. Koster, M. Kuxhausen, F. Heidenreich, L.C. de Wreede, S. Spellman, M. van Gelder, B. Bruno, F. Onida, V. Lange, C. Massalski, V. Potter, P. Ljungman, N. Schaap, P. Hayden, S.J. Lee, N. Kroger, K. Hsu, A.H. SchmidtI. Yakoub-Agha, M. Robin

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Web of Science)
Original languageEnglish
Article number584520
Number of pages12
JournalFrontiers in Immunology
Volume11
DOIs
Publication statusPublished - 19 Jan 2021

Keywords

  • diversity
  • donor selection
  • free survival
  • gene
  • hematopoietic stem cell transplantation
  • kir
  • kir2ds1
  • kir3dl1
  • ligand
  • natural-killer
  • organization
  • relapse
  • subtypes
  • therapy
  • unrelated donor
  • unrelated transplantation
  • FREE SURVIVAL
  • ORGANIZATION
  • THERAPY
  • DIVERSITY
  • LIGAND
  • UNRELATED TRANSPLANTATION
  • NATURAL-KILLER
  • KIR2DS1
  • SUBTYPES
  • KIR3DL1
  • RELAPSE
  • GENE
  • KIR

Cite this